11-120305031-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014352.4(POU2F3):c.446C>T(p.Ala149Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000329 in 1,599,614 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00014 ( 0 hom., cov: 27)
Exomes 𝑓: 0.00035 ( 1 hom. )
Consequence
POU2F3
NM_014352.4 missense, splice_region
NM_014352.4 missense, splice_region
Scores
1
7
9
Splicing: ADA: 0.9792
2
Clinical Significance
Conservation
PhyloP100: 5.78
Genes affected
POU2F3 (HGNC:19864): (POU class 2 homeobox 3) This gene encodes a member of the POU domain family of transcription factors. POU domain transcription factors bind to a specific octamer DNA motif and regulate cell type-specific differentiation pathways. The encoded protein is primarily expressed in the epidermis, and plays a critical role in keratinocyte proliferation and differentiation. The encoded protein is also a candidate tumor suppressor protein, and aberrant promoter methylation of this gene may play a role in cervical cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POU2F3 | NM_014352.4 | c.446C>T | p.Ala149Val | missense_variant, splice_region_variant | 7/13 | ENST00000543440.7 | NP_055167.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POU2F3 | ENST00000543440.7 | c.446C>T | p.Ala149Val | missense_variant, splice_region_variant | 7/13 | 1 | NM_014352.4 | ENSP00000441687.2 | ||
POU2F3 | ENST00000533620.5 | n.*112C>T | splice_region_variant, non_coding_transcript_exon_variant | 8/14 | 1 | ENSP00000435738.2 | ||||
POU2F3 | ENST00000533620.5 | n.*112C>T | 3_prime_UTR_variant | 8/14 | 1 | ENSP00000435738.2 | ||||
POU2F3 | ENST00000260264.8 | c.452C>T | p.Ala151Val | missense_variant, splice_region_variant | 7/13 | 2 | ENSP00000260264.4 |
Frequencies
GnomAD3 genomes AF: 0.000141 AC: 21AN: 148590Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
21
AN:
148590
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000246 AC: 61AN: 248370Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 134338
GnomAD3 exomes
AF:
AC:
61
AN:
248370
Hom.:
AF XY:
AC XY:
35
AN XY:
134338
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000348 AC: 505AN: 1451024Hom.: 1 Cov.: 29 AF XY: 0.000319 AC XY: 230AN XY: 721718
GnomAD4 exome
AF:
AC:
505
AN:
1451024
Hom.:
Cov.:
29
AF XY:
AC XY:
230
AN XY:
721718
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000141 AC: 21AN: 148590Hom.: 0 Cov.: 27 AF XY: 0.0000832 AC XY: 6AN XY: 72146
GnomAD4 genome
AF:
AC:
21
AN:
148590
Hom.:
Cov.:
27
AF XY:
AC XY:
6
AN XY:
72146
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
37
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.446C>T (p.A149V) alteration is located in exon 7 (coding exon 7) of the POU2F3 gene. This alteration results from a C to T substitution at nucleotide position 446, causing the alanine (A) at amino acid position 149 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;M
PrimateAI
Uncertain
T
REVEL
Uncertain
Sift4G
Uncertain
T;T
Polyphen
0.84
.;P
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at